nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of Telemedicine in Diabetes Care: The Time is Now
|
Aberer, Felix |
|
|
12 |
3 |
p. 629-639 |
artikel |
2 |
A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience
|
Zeng, Tianshu |
|
|
12 |
3 |
p. 931-941 |
artikel |
3 |
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
|
Fadini, Gian Paolo |
|
|
12 |
3 |
p. 781-800 |
artikel |
4 |
Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study
|
Pfohl, Martin |
|
|
12 |
3 |
p. 733-747 |
artikel |
5 |
Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study
|
Seufert, Jochen |
|
|
12 |
3 |
p. 749-764 |
artikel |
6 |
Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes
|
Nagai, Yoshio |
|
|
12 |
3 |
p. 897-911 |
artikel |
7 |
Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
|
Nomoto, Hiroshi |
|
|
12 |
3 |
p. 955-964 |
artikel |
8 |
Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study
|
Yoshizawa, Yuta |
|
|
12 |
3 |
p. 655-667 |
artikel |
9 |
Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
|
Seino, Hiroaki |
|
|
12 |
3 |
p. 863-877 |
artikel |
10 |
Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
|
Chehrehgosha, Haleh |
|
|
12 |
3 |
p. 843-861 |
artikel |
11 |
Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes
|
Fujikawa, Tomoki |
|
|
12 |
3 |
p. 827-842 |
artikel |
12 |
Impact of Intensive Glucose Control on Brain Health: Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus
|
Tang, Xingyao |
|
|
12 |
3 |
p. 765-779 |
artikel |
13 |
Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial
|
Chen, Liming |
|
|
12 |
3 |
p. 813-826 |
artikel |
14 |
Movement is Improvement: The Therapeutic Effects of Exercise and General Physical Activity on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Shah, Sayed Z. A. |
|
|
12 |
3 |
p. 707-732 |
artikel |
15 |
Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study
|
Lingvay, Ildiko |
|
|
12 |
3 |
p. 879-896 |
artikel |
16 |
Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study
|
Williams, David M. |
|
|
12 |
3 |
p. 801-811 |
artikel |
17 |
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study
|
Kamenov, Zdravko |
|
|
12 |
3 |
p. 913-930 |
artikel |
18 |
Risk Factors for Albuminuria in Normotensive Older Adults with Type 2 Diabetes Mellitus and Normal Renal Function: A Cross-Sectional Study
|
Zhou, Yingyi |
|
|
12 |
3 |
p. 697-705 |
artikel |
19 |
Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case–Control Study
|
Korpijaakko, Cedric |
|
|
12 |
3 |
p. 669-677 |
artikel |
20 |
Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study
|
Hepprich, Matthias |
|
|
12 |
3 |
p. 943-954 |
artikel |
21 |
The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India
|
Kalra, Sanjay |
|
|
12 |
3 |
p. 679-695 |
artikel |
22 |
What is Diabetes Remission?
|
Holst, Jens J. |
|
|
12 |
3 |
p. 641-646 |
artikel |
23 |
What’s in a Name? Redefining Type 2 Diabetes Remission
|
Kalra, Sanjay |
|
|
12 |
3 |
p. 647-654 |
artikel |